Evidence map›Paper›PMID 34117373›Full record

ArticleJournal of human genetics2021

The rare rs769301934 variant in NHLRC1 is a common cause of Lafora disease in Turkey.

Garen Haryanyan, Ozkan Ozdemir, Kemal Tutkavul, Aysin Dervent, Semih Ayta, Cigdem Ozkara, Baris Salman, Emrah Yucesan, Yesim Kesim, Seda Susgun and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Reanalysis of exome sequencing data reveals a treatable neurometabolic origin in two previously undiagnosed siblings with neurodevelopmental disorder.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Garen Haryanyan *Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Ozkan Ozdemir *Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Kemal TutkavulDepartment of Neurology, Istanbul Haydarpasa Numune Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Aysin DerventDepartment of Neurology, Pediatric Neurology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Semih AytaDepartment of Pediatrics, Child Neurology Unit, Haseki Training and Research Hospital, Istanbul, Turkey.
Cigdem OzkaraDepartment of Neurology and Clinical Neurophysiology, Cerrahpasa Medical Faculty, Istanbul University Cerrahpasa, Istanbul, Turkey.
Baris SalmanDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Emrah YucesanDepartment of Medical Biology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Yesim KesimDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Seda SusgunDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Ugur OzbekDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Betul BaykanDepartment of Neurology and Clinical Neurophysiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sibel A Ugur IseriDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. sibel.ugur@istanbul.edu.tr.ORCID http://orcid.org/0000-0002-5790-6853
Nerses BebekDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Istanbul University · TRBezmiâlem Vakıf Üniversitesi · TRKent Hastanesi · TRHaseki Eğitim ve Araştırma Hastanesi · TRHaydarpaşa Numune Eğitim ve Araştırma Hastanesi · TRIstanbul Kültür University · TRIstanbul University-Cerrahpaşa · TR

Funding

Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi (Department of Scientific Research Projects, Istanbul University) 25323Türkiye Bilimsel ve Teknolojik Araştirma Kurumu (Scientific and Technological Research Council of Turkey) 214S222
6 · The paper itself

Abstract

Lafora disease (LD) is a severe form of progressive myoclonus epilepsy inherited in an autosomal recessive fashion. It is associated with biallelic pathogenic variations in EPM2A or NHLRC1, which encode laforin and malin, respectively. The disease usually starts with adolescent onset seizures followed by progressive dementia, refractory status epilepticus and eventually death within 10 years of onset. LD is generally accepted as having a homogenous clinical course with no considerable differences between EPM2A or NHLRC1 associated forms. Nevertheless, late-onset and slow progressing forms of the disease have also been reported. Herein, we have performed clinical and genetic analyses of 14 LD patients from 12 different families and identified 8 distinct biallelic variations in these patients. Five of these variations were novel and/or associated with the LD phenotype for the first time. Interestingly, almost half of the cases were homozygous for the rare rs769301934 (NM_198586.3(NHLRC1): c.436 G > A; p.(Asp146Asn)) allele in NHLRC1. A less severe phenotype with an onset at a later age may be the reason for the biased inflation of this variant, which is already present in the human gene pool and can hence arise in the homozygous form in populations with increased parental consanguinity.

Indexed as

AllelesGenetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationConsanguinityFamilyGenotypeHumansLafora DiseasePedigreePhenotypeTurkeyUbiquitin-Protein LigasesNHLRC1 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID34117373
OpenAlexW3170830970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.